{"id":"https://openalex.org/W1983166196","doi":"https://doi.org/10.1016/0959-8049(96)84218-3","title":"PP-7-4 Phase study of taxol\u00ae (paclitaxel) in combination with epirubicin and cyclophosphamide without G-CSF as a first line treatment of metastatic breast carcinoma (MBC)","display_name":"PP-7-4 Phase study of taxol\u00ae (paclitaxel) in combination with epirubicin and cyclophosphamide without G-CSF as a first line treatment of metastatic breast carcinoma (MBC)","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W1983166196","doi":"https://doi.org/10.1016/0959-8049(96)84218-3","mag":"1983166196"},"language":"en","primary_location":{"id":"doi:10.1016/0959-8049(96)84218-3","doi":"https://doi.org/10.1016/0959-8049(96)84218-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0959-8049(96)84218-3","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083338594","display_name":"Monique Hulin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143498","display_name":"Japan Breast Cancer Research Group","ror":"https://ror.org/055ybk671","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210143498"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M.Tubiana Hulin","raw_affiliation_strings":["BMS Breast Cancer French Study Group, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BMS Breast Cancer French Study Group, France","institution_ids":["https://openalex.org/I4210143498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032321264","display_name":"Gilles Catimel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143498","display_name":"Japan Breast Cancer Research Group","ror":"https://ror.org/055ybk671","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210143498"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"G. Catimel","raw_affiliation_strings":["BMS Breast Cancer French Study Group, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BMS Breast Cancer French Study Group, France","institution_ids":["https://openalex.org/I4210143498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024118579","display_name":"Jacques M Bonneterre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143498","display_name":"Japan Breast Cancer Research Group","ror":"https://ror.org/055ybk671","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210143498"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"J. Bonneterre","raw_affiliation_strings":["BMS Breast Cancer French Study Group, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BMS Breast Cancer French Study Group, France","institution_ids":["https://openalex.org/I4210143498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110051919","display_name":"J.A. Soares","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098725","display_name":"Bristol-Myers Squibb (France)","ror":"https://ror.org/013b57229","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210098725"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J.A. Soares","raw_affiliation_strings":["Bristol-Myers Squibb, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, France","institution_ids":["https://openalex.org/I4210098725"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005207507","display_name":"Michel Chazard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098725","display_name":"Bristol-Myers Squibb (France)","ror":"https://ror.org/013b57229","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210098725"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Chazard","raw_affiliation_strings":["Bristol-Myers Squibb, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, France","institution_ids":["https://openalex.org/I4210098725"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4270,"currency":"USD","value_usd":4270},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.1200615,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":null,"first_page":"45","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.04729999974370003,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9890000224113464},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.8870000243186951},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":1.0},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.7599999904632568},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.8610000014305115},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.9528393149375916},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7912715673446655},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7142305374145508},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6422028541564941},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5836242437362671},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5769719481468201},{"id":"https://openalex.org/C3018521938","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast carcinoma","level":4,"score":0.5233551859855652},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4945618808269501},{"id":"https://openalex.org/C2993493390","wikidata":"https://www.wikidata.org/wiki/Q5453208","display_name":"First line","level":2,"score":0.44093987345695496},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.35453587770462036},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.1441017985343933},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.12972965836524963}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/0959-8049(96)84218-3","doi":"https://doi.org/10.1016/0959-8049(96)84218-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0959-8049(96)84218-3","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2005619753","https://openalex.org/W2049487146","https://openalex.org/W2009348334","https://openalex.org/W1999802096","https://openalex.org/W2052492932","https://openalex.org/W2023311156","https://openalex.org/W2024022527","https://openalex.org/W2025721769","https://openalex.org/W2059258040","https://openalex.org/W2100823502"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}